BridgeBio Pharma - 5 Year Stock Split History | BBIO
Stock split history for BridgeBio Pharma since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| BridgeBio Pharma Annual Stock Splits |
|---|
| BridgeBio Pharma Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $4.477B | $0.009B |
| BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.585B | 5.27 |
| Dr Reddy's Laboratories (RDY) | India | $11.930B | 18.86 |
| Aspen Pharmacare (APNHY) | South Africa | $4.985B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.117B | 2.43 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.999B | 13.68 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.639B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.473B | 0.00 |
| Generation Bio (GBIO) | United States | $0.217B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.073B | 0.00 |
| Personalis (PSNL) | United States | $0.070B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |